Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03427879Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by Utah State University. Primary endpoints: Urinary lactulose:mannitol ratio at 3 weeks and Plasma intestinal fatty acid binding protein at 3 weeks. Started Sep 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03427879.